Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01592071 · ClinicalTrials.gov registry record · NA

IgG-mediated Food Test for Weight Loss

A NA study of Overweight and Obesity, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01592071: Completed NA study of Overweight and Obesity, sponsored by University of Miami.

NCT01592071 is a NA study of Overweight and Obesity that has completed, run by University of Miami. The registered enrollment target is 120 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01592071, a NA study of Overweight and Obesity, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study assessed the effect of an IgG-mediated food sensitivity test in combination with a food elimination diet on body composition and secondary outcomes in people who were overweight.

Primary Outcome

Measure of body composition: weight (kg).

Conditions Studied

Interventions

  • OTHER Replace reactive foods with non-reactive foods

Study Locations (1)

Florida

  • University of Miami CRB - Miami

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2008-10
Est. Completion 2010-10
Phase NA
University of Miami

721 total trials

What the finished NCT01592071 record still lists

NCT01592071 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (47% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which Replace reactive foods with non-reactive foods is the first listed.

NCT01592071 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01592071 about?

NCT01592071 is a clinical study titled "IgG-mediated Food Test for Weight Loss". This study assessed the effect of an IgG-mediated food sensitivity test in combination with a food elimination diet on body composition and secondary outcomes in people who were overweight.

What is the current status of trial NCT01592071?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2008-10. Estimated completion is 2010-10.

What conditions does trial NCT01592071 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT01592071?

The interventions under investigation include: Replace reactive foods with non-reactive foods (OTHER).

Who is sponsoring clinical trial NCT01592071?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01592071 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01592071's enrollment target sits among peer trials

120 52nd of 115 higher than 63 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01592071, the US trial registry maintained by the National Library of Medicine. NCT01592071 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.